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Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease characterized by age-dependent degeneration of dopaminergic neurons 1, 2 . The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. Drosophila e2f1 and dp messenger RNAs are translationally repressed by let-7 and miR-184*, respectively. Pathogenic LRRK2 antagonizes these miRNAs, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control 3 and shown here to be critical for LRRK2 pathogenesis. Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic LRRK2. Conversely, increasing the level of let-7 or miR-184* attenuated pathogenic LRRK2 effects. LRRK2 associated with Drosophila Argonaute-1 (dAgo1) or human Argonaute-2 (hAgo2) of the RNA-induced silencing complex (RISC). In aged fly brain, dAgo1 protein level was negatively regulated by LRRK2. Further, pathogenic LRRK2 promoted the association of phospho-4E-BP1 with hAgo2. Our results implicate deregulated synthesis of E2F1/DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel miRNA-based therapeutic strategies.
Analyses of Dicer knockout mice have implicated the miRNA pathway in maintaining post-mitotic neurons 4, 5 . To test whether LRRK2 might affect miRNA function, we generated an in vivo enhanced green fluorescent protein (EGFP) reporter with let-7-binding sites in the 39 untranslated region (UTR) (EGFP-let-7-39UTR). The loss of one copy of Drosophila dicer-1 or argonaute 1 (ago1) genes of the miRNA pathway enhanced reporter expression (Fig. 1a) , suggesting that this reporter faithfully monitors endogenous miRNA activity. Daughterless (Da)-Gal4-directed ubiquitous or tyrosine hydroxylase (TH)-Gal4-directed dopaminergic-neuron-specific coexpression of pathogenic dLRRK(I1915T) or hLRRK2(G2019S) all stimulated reporter expression, more so than wild-type proteins (Fig. 1a, b ). This effect was correlated with differential toxicity 6 rather than expression levels of the proteins, because the pathogenic proteins were actually expressed at lower levels (Fig. 2a) . dLRRK RNAmediated interference (RNAi) led to decreased reporter expression, indicating that endogenous dLRRK also affects miRNA function (Fig. 1a) . The kinase-dead dLRRK(3KD) did not affect reporter expression ( Fig. 1a and Supplementary Fig. 1a ). This result, together with the observation that I1915T and G2019S mutations augmented kinase activity 7, 8 , suggests that the effect of LRRK2 is kinase dependent. Levels of gfp mRNA were not affected ( Supplementary Fig. 1b, c) . Moreover, the expression of an EGFP transgene without let-7-binding sites in the 39 UTR was not affected by dLRRK(I1915T) (Supplementary Fig. 3a ). LRRK2 thus antagonizes let-7 function at the translational level.
We further tested the effect of pathogenic LRRK2 on miRNAregulated translation in HEK293T cells, using a luciferase reporter harbouring let-7-binding sites in the 39 UTR 9 . hLRRK2(I2020T) or hLRRK2(G2019S) efficiently suppressed the inhibitory effect of let-7 on reporter expression ( Supplementary Fig. 2a, b) . The introduction of kinase-inactivating mutations (3KD) into hLRRK2-G2019S or hLRRK2-I2020T abolished the effects of these proteins on reporter expression ( Supplementary Fig. 2b ), supporting the dependence of pathogenic LRRK2 action on kinase activity. Mutant hLRRK2 carrying another pathogenic mutation, R1441G, had no effect on let-7 miRNA function ( Supplementary Fig. 2b ), and transgenic flies expressing dLRRK carrying the equivalent R1069G mutation showed no loss of dopaminergic neurons ( Supplementary Fig. 2c ), suggesting that this mutation acts through a different mechanism.
We next investigated how LRRK2 regulates miRNA function. No significant change in let-7 level in hLRRK2(G2019S) or dLRRK(I1915T) transgenics was detected ( Supplementary Fig. 4a ). We examined whether LRRK2 impairs miRNA function through RISC components 10 . In fly dopaminergic neurons, hLRRK2 and dAgo1 were both cytoplasmic and partly co-localized (Supplementary Fig. 5a ). In co-immunoprecipitation assays, transfected hLRRK2 associated with hAgo2 in HEK293T cells (Fig. 1c) , transgenic hLRRK2 associated with dAgo1 in fly head extracts (Fig. 1f) , and endogenous hLRRK2 or dLRRK associated with hAgo2 or dAgo1, respectively (Fig. 1d, e and Supplementary Fig. 6b ). Because similar co-immunoprecipitation results were obtained with (Fig. 1c, f) or without ( Supplementary Fig. 6a , c) treatment of extracts with RNase A, the interaction was probably direct and not mediated by RNA.
We examined the physiological consequence of the interaction between LRRK2 and dAgo1. Although no significant change in dAgo1 level was observed in young flies ( Supplementary Fig. 7a ), in aged flies dAgo1 protein was significantly decreased by pathogenic hLRRK2 (Fig. 1g and Supplementary Fig. 5b) . Conversely, the level of dAgo1 was increased in a dLRRK mutant ( Fig. 1g and Supplementary  Fig. 7a ). Consistent with a negative regulation of dAgo1 by LRRK2, ago1 heterozygosity exacerbated the climbing defect ( Supplementary  Fig. 8b ) and dopaminergic-neuron-loss phenotypes (Fig. 1i) in pathogenic dLRRK or hLRRK2 transgenics. The aged ago1 heterozygote showed a roughly 26% decrease in dAgo1 protein compared with the control and did not show obvious phenotypes ( Fig. 1i and Supplementary Fig. 7b ). We also examined genetic interaction between LRRK2 and Dicer1. In TH-Gal4.dLRRK(I1915T) background, Dicer1 overexpression suppressed dLRRK(I1915T) toxicity but Dicer1 RNAi exacerbated it, although similar manipulations in a wild-type background had no obvious effect ( Fig. 1h and Supplementary Fig. 8a ). However, stronger inhibition of Dicer1 by Dicer1 RNAi in a dicer1 heterozygous background did result in dopaminergic neuron loss and climbing defects ( Fig. 1j and Supplementary  Fig. 8c ), which were partly decreased by dLRRK RNAi ( Supplementary  Figs 8d and 19a) . Because decreasing bulk translation through the overexpression of active forms of 4E-BP did not rescue the toxicity of Dicer1 knockdown (data not shown), the rescue by dLRRK RNAi may not be attributable to decreased bulk translation. These results support a specific link between LRRK2 and the miRNA pathway.
Because the miRNA-antagonizing function of LRRK2 is kinase dependent, we investigated possible interaction between the miRNA pathway and LRRK2 substrate 4E-BP (ref. 6 ). 4E-BP1 associated with hAgo2 in HEK293T cells (Supplementary Fig. 10a ). dLRRK(I1915T) and hLRRK2(G2019S) promoted this interaction more effectively than wild-type proteins did. This presumably resulted from increased phosphorylation of 4E-BP1 by pathogenic LRRK2 (ref. 6) , and preferential binding of phospho-4E-BP1 to hAgo2 ( Supplementary  Fig. 10b, c) . Moreover, the phospho-mimetic 4E-BP carrying T to E mutations (4E-BP(TE)) was more effective than wild-type 4E-BP (4E-BP(WT)) or non-phosphorylatable 4E-BP carrying T to A mutations (4E-BP(TA)) in attenuating the effect of let-7 in vivo or in 4E-BP1(2/ 2) mouse embryonic fibroblast (MEF) cells ( Supplementary Fig. 10d , e), and overexpression of 4E-BP(TE) was toxic to dopaminergic neurons ( Supplementary Fig. 10f, g ). Because no change in dAgo1 level was detected in aged Da-Gal4.d4E-BP(TE) animals ( Supplementary  Fig. 10h ), and loss of dAgo2 had no effect on dopaminergic neuron number ( Supplementary Fig. 10i ), phospho-4E-BP effect is unlikely to be through the regulation of dAgo1 or dAgo2. Pathogenic hLRRK2 with hyperactive kinase activity thus promotes the association of phospho-4E-BP with hAgo2, relieving miRNA-mediated translational repression. Non-phosphorylatable 4E-BP(TA) consistently blocked the effect of hLRRK2(G2019S) in antagonizing let-7 (Supplementary Fig. 10j) .
We next sought to identify mRNA targets whose translation is upregulated by pathogenic LRRK2. Da-Gal4.dLRRK(WT) or DaGal4.dLRRK(I1915T) fly heads were subjected to mRNA translational profiling 11 . From a list of candidate genes showing differential polysome association (Supplementary Table 1 ), we chose e2f1 and dp for further analysis, because previous studies have implicated E2F deregulation in Parkinson's disease 12 . Treatment with puromycin, which specifically releases actively translating polysomes, showed that most e2f1 and dp mRNAs were associated with active polysomes ( Supplementary Fig. 11b ). Western blot analysis confirmed the upregulation of E2F1 and DP by dLRRK(I1915T) or hLRRK2(G2019S) ( Fig. 2a and Supplementary Fig. 12a, b) ; conversely, both proteins were downregulated in dLRRK(2/2) mutant (Fig. 2b) , with mRNA levels not significantly changed in both conditions ( Supplementary  Fig. 12c, d ). Removing one copy of e2f1 or dp, or overexpressing the Drosophila retinoblastoma homologue RBF, a negative regulator of E2F1/DP 13 , suppressed the dopaminergic neuron phenotypes in THGal4.dLRRK(I1915T) animals (Fig. 2c) . Removing one copy of lkb1, another potential target identified by translational profiling, showed no effect (Fig. 2c) . Removing one copy of e2f1 or dp, but not lkb1, also
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Da-Gal4 dLRRK attenuated the sensitivity of Da-Gal4.dLRRK(I1915T) transgenics to oxidative stress ( Supplementary Fig. 13 ).
To test whether dLRRK and hLRRK2 affect the translation of E2F1 and DP through the miRNA pathway, we used the RNAhybrid algorithm to predict potential miRNA-binding sites within e2f1-39 UTR and dp-39 UTR. One candidate miR-184*-binding site in e2f1-39 UTR responded to miR-184* activity in reporter assays (Fig. 3a) . Mutating two central nucleotides in the seed sequence completely abolished this miR-184* effect ( Fig. 3c and Supplementary Fig. 16a ). Similarly, we identified one functional let-7-binding site within dp-39 UTR (Fig. 3d, f and Supplementary Fig. 16b ). Co-transfection of pathogenic hLRRK2 strongly relieved the repressive effects of let-7 and miR-184* on the expression of dp-39 UTR or e2f1-39 UTR reporters, respectively (Fig. 3b, e) .
To test whether let-7 and miR-184* regulate endogenous e2f1 and dp translation, we overexpressed precursor (pre)-miRNAs or injected synthetic mature miRNAs into wild-type fly heads. Ubiquitous overexpression of pre-let-7 ( Supplementary Fig. 4b ) or injection of synthetic let-7 ( Supplementary Fig. 3b ) significantly decreased the level of DP in head extracts (Fig. 4a, b) . Overexpressed pre-miR-184* or injected miR-184* decreased the level of E2F1 (Fig. 4a, b) , validating E2F1 and DP as in vivo targets of miR-184* and let-7. Overexpression of pre-let-7 or pre-miR-184* specifically in dopaminergic neurons or injection of mature miRNA partly rescued TH-Gal4.dLRRK(I1915T) mutant phenotypes, whereas injection of buffer or control miR-10 had no effect (Fig. 4a, b and Supplementary Fig. 8e ). Injection of miRNAs into wild-type fly heads also had no effect (Supplementary Fig. 8g ).
Regulation of E2F1 and DP by miRNA is therefore causally involved in dLRRK(I1915T) pathogenesis.
We further tested whether inhibition of let-7 or miR-184* function in wild-type animals is sufficient to phenocopy pathogenic LRRK2. We first verified that let-7 is expressed in dopaminergic neurons ( Supplementary Fig. 14) . Homozygous let-7 mutant (Dlet-7) showed decreased locomotor activity and a specific decrease in dopaminergic neurons, which could be rescued by a let-7 transgene (Fig. 4c and Supplementary Figs 8f and 15c, d) . Consistent with let-7 regulating DP expression in vivo, the DP level was increased in Dlet-7 animals (Fig. 4c) . Removing one copy of dp or e2f1 suppressed Dlet-7 mutant phenotypes (Fig. 4c and Supplementary Fig. 8f ). These results support the notion that DP overproduction contributes significantly to Dlet-7 phenotypes. Alternatively, we injected antagomirs into fly heads to block miRNA function. Injected anti-let-7fS attenuated endogenous let-7 function in dopaminergic neurons (Supplementary Fig.  3b ). Injection of anti-let-7fS into wild-type flies increased the DP level in head extracts, whereas a control antagomir (anti-let-7mutfS) had no effect. Similarly, anti-miR-184*fS increased the E2F1 level (Fig. 4d) . Injection of anti-let-7fS and anti-miR-184*fS resulted in a specific loss of dopaminergic neurons (Fig. 4d and Supplementary Fig. 15a, b) , and decreased climbing activity ( Supplementary Fig. 9c ). In comparison, injection of anti-let-7fS into a dLRRK mutant failed to produce such effects ( Supplementary Fig. 9a ), suggesting that the miRNA pathway is more robust when dLRRK is absent. The toxic effects of anti-miR-184*fS and anti-let-7fS were attenuated by e2f1/1 or dp/1 heterozygosity ( Supplementary Fig. 9b, c) , supporting the notion that E2F1/DP are important mediators of antagomir toxicity. Consistently, E2F1 overexpression is sufficient to cause the degeneration of dopaminergic neurons and decreased locomotor activity (Supplementary Figs 9f and 15e) .
To prove more conclusively the critical role of the specific miRNA-mRNA interactions in dopaminergic neurons, we employed two approaches. First, we generated transgenics expressing a dp target protector (dp-TP let-7 ; Supplementary Fig. 16d ), which is expected to interfere specifically with let-7-miRNA/dp mRNA 39 UTR interaction 14 . dp-TP let-7 is functional in a reporter assay ( Supplementary  Fig. 18a ). Ubiquitous expression of dp-TP let-7 using Da-Gal4 resulted in DP overproduction without affecting the dp mRNA level (Fig. 4e and Supplementary Fig. 18b) , and TH-Gal4-driven dp-TP let-7 expression led to a loss of dopaminergic neurons and decreased climbing activity (Fig. 4e and Supplementary Figs 9d and 19b) . Second, we generated genomic transgenes expressing a mutant form of dp (gDPmut) with potential let-7-binding sites rendered nonfunctional ( Supplementary Fig. 16b, c) . In comparison with the wild-type gDPwt, gDPmut caused DP accumulation in a dp Df/1 background (Fig. 4f) . Although both gDPwt and gDPmut rescued the viability of Df/dpR217H transheterozygote, gDPmut-rescued animals showed a loss of dopaminergic neurons and locomotor defects ( Fig. 4f and Supplementary Figs 9e and 19c) . Taken together, these in vivo studies establish the importance of LRRK2-regulated interaction between let-7-miRNA and dp mRNA in dopaminergic neurons. Glass multiple reporter (GMR)-Gal4-driven dLRRK(I1915T) expression in the eye did not affect the activities of bantam and miR-14 miRNAs ( Supplementary Fig. 17a, b) , which protect against neurodegeneration induced by MJD.tr-Q78 and Reaper, respectively 15, 16 . Thus, pathogenic dLRRK may regulate miRNA function in a miRNA-specific and/or tissue-specific manner. The recent identification of let-7 miRNA-specific ribonucleoprotein complexes supports miRNA-specific regulation 17 . We have identified let-7 and miR-184* and their targets E2F1 and DP as critical mediators of pathogenic LRRK2 in dopaminergic neurons. E2F1 and DP are better known for their roles in driving the cell cycle. In post-mitotic neurons their upregulation may lead to abortive cell division and cell death, as shown in dopaminergic neurons of patients with Parkinson's disease and in animal models 12 . Mechanistically, pathogenic LRRK2 associates with and regulates dAgo1 stability and promotes the association of phospho-4E-BP with Values represent EGFP levels in the transgenic crosses relative to the control from three independent experiments (asterisk, P , 0.05, n 5 3). Tubulin served as a loading control. Fly head extracts prepared from 35-day-old flies raised at 29 uC were used. b, Western blot analysis of E2F1 and DP levels (asterisk, P , 0.05, n 5 3) in dLRRK mutant and wild-type animals. c, Effects of e2f1, dp or lkb1 heterozygosity, or overexpression of rbf, on dopaminergic neuron number (n 5 3′ UTR + + + dp dp dp(743-2mut) showing the response of the 39 UTRs of Drosophila e2f1 (a) and dp (d) to exogenous let-7 and miR-184*, with miR-124 serving as a control (asterisk, P , 0.05, n 5 3). RT-PCR measures the level of luciferase mRNA, with b-actin serving as a control. b, e, Reporter assays showing the effects of wild-type, 3KD and pathogenic forms of hLRRK2 on miRNA-mediated regulation of e2f1-39 UTR (b) and dp-39 UTR (e) (asterisk, P , 0.05, n 5 3). c, f, Reporter assays using e2f1-39 UTR and dp-39 UTR containing mutagenized seed sequences in let-7-binding or miR-184*-binding sites (asterisk, P , 0.05, n 5 3). Luciferase activity was normalized with Renilla mRNA level in all assays. Error bars represent s.d. +/+
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Da-Gal4 Figure 4 | Regulated E2F1 and DP translation by let-7 and miR-184* impacts on dopaminergic neuron maintenance and function in vivo. a, Effects of pre-let-7 and pre-miR-184* on DP and E2F1 level (left, asterisk, P , 0.05, n 5 3) and dopaminergic neuron number (right, asterisk, P , 0.05, n 5 6). b, Effects of injected mature let-7 and miR-184* miRNAs on DP and E2F1 level (left, asterisk, P , 0.05, n 5 3) and dopaminergic neuron number (right, asterisk, P , 0.05, n 5 16). w 2 , wild type. c, DP level (left; asterisk, P , 0.05, n 5 3) and dopaminergic neuron number (right; asterisk, P , 0.05, n 5 6) in the indicated genotypes. d, Effects of let-7 and miR-184* antagomir injection on E2F1 and DP levels (left; asterisk, P , 0.05, n 5 3) and dopaminergic neuron number (right; asterisk, P , 0.05, n 5 6) in wild-type flies. Anti-let-7mutfS served as control. e, Effect of ubiquitous dp-TP control or dp-TP let-7 expression on DP level (left; asterisk, P , 0.05, n 5 3) or dopaminergic-neuron-specific expression on dopaminergic neuron number (right; asterisk, P , 0.004, n 5 15). f, Effects of gDPwt and gDPmut transgene expression on DP level in dp Df/1 heterozygous background (left; asterisk, P , 0.05, n 5 3) and dopaminergic neuron number (right; asterisk, P , 0.015, n 5 5). Flies were raised at 29 uC for 33 days. Error bars represent s.d.
dAgo1. The exact mechanism of phospho-4E-BP action in this process and the potential involvement of other LRRK2 targets await further investigation. Overexpression of 4E-BP was first shown to be neuroprotective in the LRRK2 model 6 , and was later extended to other models of Parkinson's disease 18 , supporting a general role of deregulated protein translation in Parkinsonism. The fact that the effects of LRRK2 manifest only in aged animals suggests that LRRK2 is particularly important for miRNA regulation under stress conditions, in which the function of 4E-BP is also most pronounced 19 . This may have implications for understanding the pathogenesis of Parkinson's disease.
METHODS SUMMARY
Counting of TH-staining and FMRFamide (Phe-Met-Arg-Phe-NH 2 )-staining neurons was performed by whole-mount immunostaining of brain samples from adult flies raised at 25 uC for 65 days, unless otherwise indicated. . UAS-dLRRK, UAS-4E-BP, UAS-4E-BP(TA), UAS-dLRRK RNAi and dLRRK mutant lines were used as described 6 . The UAS-eIF4E RNAi and UAS-dicer1 RNAi flies were obtained from the Vienna Drosophila RNAi Center, and UASdicer1 flies from B. Dickson; UAS-rbf and UAS-e2f1 were requested from B. 16 ; and UAS-banD was from S. Cohen 28 . The Dlet-7 mutant, Dlet-7 mutant rescued with a let-7 transgene, and let-7-C-Gal4 flies were as described 29 . All other stocks are from Bloomington Drosophila Stock Center. The 4E-BP1-depleted MEF line was obtained from N. Sonenberg 30 . The oxidative stress assay and climbing activity assay were performed essentially as described 6 . To measure climbing activity, we used flies aged at 25 uC for 65 days unless otherwise indicated. Each measurement was repeated with three independent fly cohorts per genotype. Unpaired Student's t-tests were used for statistical analysis between two groups and one-way analysis of variance was used for statistical analysis involving more than two experimental groups. The RNAhybrid algorithm (http:// bibiserv.techfak.uni-bielefeld.de/rnahybrid/submission.html) was used to predict potential miRNA target sites.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. 
METHODS
Isolation of polysomal mRNA, complementary DNA synthesis and DNA microarray analysis. Four hundred fly heads (50% males and 50% females of 25-day-old flies) were dissected in ice-cold dissection buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 2 mM KH 2 PO 4 pH 7.4, 0.1 mg ml 21 cycloheximide (Sigma), 0.05% Triton X-100). Fly heads were transferred to extraction buffer (125 mM sucrose, 25 mM HEPES pH 6.9, 100 mM KCl, 5 mM mgCl 2 , 1 mM dithiothreitol (DTT) supplemented with RNase inhibitor and Complete protease inhibitor cocktail) and subjected to ten strokes of homogenization in a pre-chilled homogenizer. The extract was centrifuged at 9,300g. for 5 min at 4 uC and loaded on the top of 10-50% sucrose gradients prepared in 300 mM NaCl, 15 mM mgCl 2 , 15 mM Tris-HCl pH 7.5, containing 0.1 mg ml 21 cycloheximide. After centrifugation at 35,000 r.p.m. for 3 h at 4 uC on an SW40Ti rotor (Beckman), fractions were harvested from the bottom. The RNA from each polysomal fraction (fractions 2-7) was extracted with guanidinium chloride and precipitated with 100% ethanol. Equal amounts of mRNA were reverse transcribed into cDNA and amplified with a SMART PCR cDNA Synthesis Kit (Clontech) in accordance with the manufacturer's recommendation. The Klenow fragment was used to incorporate biotin-16-dUTP (Roche) into the cDNA. After a subsequent treatment with DNase I, the fragmented and biotinylated cDNA was hybridized onto the Drosophila Genome 2.0 Array (Affymetrix) and data were analysed in accordance with the manufacturer's instruction. Quantitative real-time PCR, reverse-transcription PCR and northern blot analysis of gene expression. Total RNA was extracted from fly heads with an RNeasy Mini kit (Qiagen). Quantitative real-time PCR (qPCR) was performed with an ABI PRISM 7700 (Applied Biosystems) and Power SYBR Green PCR Master Mix (Applied Biosystems) as a one-step reaction mixture supplemented with Superscript Reverse Transcriptase (LifeTechnologies) and sequence-specific primers, in accordance with the manufacturer's protocol. Data were generated from three independent qPCR reactions and normalized with rp49 mRNA level as control.
For RT-PCR analysis, total RNA was extracted from fly heads with an RNeasy Mini kit and one-step RT-PCR was performed with an RT-PCR kit (Qiagen). For RT-PCR analysis of polysomal mRNAs, we prepared extracts from 150 fly heads and incubated the extracts in the presence of RNase inhibitor (protectRNA; Sigma) and 0.1 mg ml 21 cycloheximide or 1 mM puromycin for 2 h at 37 uC and subsequently fractionated on 10-50% sucrose gradients. Fractions 2-7 from the bottom were pooled, RNA was extracted, and one-step RT-PCR was performed with the RT-PCR kit.
The primer sequences were as follows: rp49 internal control, 59-CCAAGGACTTCATCCGCCACC-39 (59 primer) and 59-GCGGGTGCGCTTG TTCGATCC-39 (39 primer); b-actin internal control, 59-GCGGGAAATCGTG CGTGACATT-39 (59 primer) and 59-GATGGAGTTTGAAGGTAGTTTCGTG-39 (39 primer); Drosophila dp, 59-GAGCTGATGGTGCCGCCG-39 (59 primer) and 59-GGGCATGTGGTTTCGCGG-39 (39 primer); Drosophila e2f1, 59-CAA CACAAAATTGCCGCG-39 and 59-GGCTGGGACTGCTTGGCGG-39 (39 primer); Renilla luciferase, 59-ATGACTTCGAAAGTTTATGTCC-39 (59 primer) and 59-CTCGAAGCGGCCGCTCTCTAG-39 (39 primer); egfp, 59-GGGCATC GACTTCAAGGAGG-39 (59 primer) and 59-TCGCGCTTCTCGTTGGGG-39 (39 primer). Northern blot analysis was performed essentially as described elsewhere 20 . Immunohistochemistry, immunoprecipitation and western blot analysis. Fly brains were dissected and fixed at 4 uC for 2 h in PBS pH 7.2 containing 4% paraformaldehyde and 0.3% Triton X-100. After three washing steps, primary antibodies against TH (1:1,000 dilution; Immunostar) and FMRFamide (1:2,000, gift from C. Zeng) were incubated overnight at 4 uC in the presence of 5% normal goat serum. As secondary antibodies we used Alexa Fluor 568-conjugated goat anti-mouse and Alexa Fluor 488-conjugated goat anti-rabbit (1:500; Molecular Probes). Immunofluorescence analysis was performed with a Carl Zeiss laser-scanning confocal microscope. A Nikon Eclipse 3000 fluorescence microscope was used for live imaging.
For immunoprecipitation, cell extracts of HEK293T and fly heads were homogenized in lysis buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM EDTA, 10% glycerol, 1% Triton X-100, 0.5 mM DTT, 60 mM b-glycerophosphate, 1 mM sodium vanadate, 20 mM NaF and complete inhibitor cocktail (Roche)). After centrifugation at 16,000g for 10 min, the supernatant was subjected to immunoprecipitation for 4 h at 4 uC with the indicated antibodies. Immunocomplexes were washed three times for 5 min each at 4 uC. For immunoprecipitation of endogenous fly proteins, fly heads were homogenized in lysis buffer and fractionated with 10-50% sucrose gradients. Fractions 9 and 10 from the top were pooled and co-immunoprecipitation of dAgo1 and dLRRK was performed. For co-immunoprecipitation in HEK293 cells, cells were co-transfected with the indicated plasmids. At 48 h after transfection, cells were harvested in lysis buffer and subjected to immunoprecipitation as described above.
To prepare head extracts for western blotting, four fly heads were directly homogenized in SDS sample buffer (10 ml per head) with a hand-held motorized homogenizer. After centrifugation at 16,000g for 10 min, the extract was separated on a 10% SDS-PAGE gel, transferred to Hybond P membrane and detected with an Enhanced Chemiluminescence Plus Western Blotting Detection kit (Amersham). The following primary antibodies were used: Drosophila DP 22 
